Delivery Order SPE2DR25D2206-SPE2DR26F9DR9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,094.52 to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100 count) on June 4, 2025, with an ultimate completion date of June 5, 2025. This firm fixed-price contract utilizes no set-aside designation and was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,957.52 to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100 count) on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Adderall XR 30 mg capsules (100-count units) with a ceiling value of $1,059.74. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The ultimate completion date for this delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a ceiling value of $1,457.08. This non-set-aside, firm fixed-price delivery order is scheduled for completion by December 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Adderall XR 10 mg capsules (100-count) with a ceiling value of $2,177.29. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The order is scheduled for completion by December 9, 2025, with performance originating...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (quantity: 100 count) on December 4, 2025, with a ceiling value of $2,321.68 and an ultimate completion date of December 5, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a ceiling value of $1,507.26. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is set for ultimate completion by December 9, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,156.08 to AmerisourceBergen Drug Corp for Adderall XR 25 mg capsules (100 count) on December 8, 2025, with completion scheduled for December 9, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a contract ceiling value of $2,415.15. This is a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, and carries no set-aside designation, indicating it was awarded through open competition. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a contract ceiling value of $3,433.81. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of April 25, 2025, and will be performed at the contractor's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9DR9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100-count) on December 1, 2025, with an ultimate completion date of December 2, 2025. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,028.18 and involves no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor serving military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company supplies a comprehensive portfolio of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains. This delivery order exemplifies the company's role in supplying controlled pharmaceutical substances to support military healthcare operations, consistent with its extensive contract portfolio spanning diverse medical products and therapeutic applications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 11/30/25 |